Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAIDs in Axial Spondyloarthritis
NCT03473665Phase 4Terminated
- Sponsor
- Columbia University
- Start
- Mar 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indomethacin, diclofenac, meloxicam, celecoxib oral solution in ankylosing spondylitis (AS), axial spondyloarthritis (axSpA), sponsored by Columbia University. Started Mar 2018; status: terminated.
02
Drugs
indomethacindiclofenacmeloxicamcelecoxib oral solution
03
Conditions
ankylosing spondylitis (AS)axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT03473665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03473665.